Sotuletinib dihydrochloride

Modify Date: 2025-08-25 11:21:49

Sotuletinib dihydrochloride Structure
Sotuletinib dihydrochloride structure
Common Name Sotuletinib dihydrochloride
CAS Number 2222138-40-9 Molecular Weight 471.40
Density N/A Boiling Point N/A
Molecular Formula C20H24Cl2N4O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Sotuletinib dihydrochloride


Sotuletinib (BLZ945) dihydrochloride is an orally active and blood-brain barrier-permeable CSF1-R-specific inhibitor (IC50=1 nM). Sotuletinib (BLZ945) dihydrochloride induces tumor cell apoptosis and effectively inhibits tumor growth in mouse models. Sotuletinib dihydrochloride can be used in cancer and amyotrophic lateral sclerosis (ALS) research[1].

 Names

Name Sotuletinib dihydrochloride

 Sotuletinib dihydrochloride Biological Activity

Description Sotuletinib (BLZ945) dihydrochloride is an orally active and blood-brain barrier-permeable CSF1-R-specific inhibitor (IC50=1 nM). Sotuletinib (BLZ945) dihydrochloride induces tumor cell apoptosis and effectively inhibits tumor growth in mouse models. Sotuletinib dihydrochloride can be used in cancer and amyotrophic lateral sclerosis (ALS) research[1].
Related Catalog
Target

IC50: CSF1-R (1 nM)[1].

References

[1]. Pyonteck SM, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013 Oct;19(10):1264-72.  

[2]. Pognan F, et al. Liver enzyme delayed clearance in rat treated by CSF1 receptor specific antagonist Sotuletinib. Curr Res Toxicol. 2022 Oct 29;3:100091.  

 Chemical & Physical Properties

Molecular Formula C20H24Cl2N4O3S
Molecular Weight 471.40
InChIKey ZIHWHYXECXSBNA-LVVRIOTCSA-N
SMILES CNC(=O)c1cc(Oc2ccc3nc(NC4CCCCC4O)sc3c2)ccn1.Cl.Cl
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.